Idarucizumab (Praxbind) is a fully humanized, monoclonal antibody which is a specific antidote to reverse the anticoagulant effect of dabigatran etexilate (Pradaxa). Idarucizumab is approved …

Join us in Barcelona at the ESOC congress 10-12 May.

You will find us in booth 36 & 37.

Welcome!…

The SITS Report 2015 has just been released and can be downloaded as pdf! Happy New Year 2016 to all SITS participants!

Download your copy …

We are sorry for the incorrect information in our last SITS Report in 2014.

Correction: During 2004 to 2014 our National Coordinator in Slovakia was …

Welcome to the SITS User meeting at ESMINT Congress on Sept 12, 12.30 (Local time). We will show you how to use the SITS registry …

We welcome Dr Valeria Caso to SITS Scientific Committee and Dr Michael Mazya to SITS International Coordination office.

Valeria Caso MD, PhD, President Elect of …

Inbjudan till deltagande
i studierna SITS ICH och SITS TNK

Kära kollega i strokevården i Sverige,

Med detta brev vill vi bjuda in dig och …